Sanofi Indicted Over Toxic Emissions at Mourenx Plant

The pharmaceutical giant faces charges for environmental violations but avoids accusations of endangering lives.

Sanofi has been indicted for environmental infractions linked to toxic emissions from its Mourenx factory in France between 1978 and 2018.
The charges include obstruction of an environmental inspection, operating without adhering to regulations, and failure to report incidents.
The company avoided the more severe charge of endangering lives and is currently classified as an assisted witness for this accusation.
Investigations revealed emissions of valproate of sodium, the active ingredient in Dépakine, at levels far exceeding safety standards, with concerns about health impacts on workers and nearby residents.
At least 15 residents, alleging health issues similar to Dépakine exposure, have joined the case as civil parties, supported by advocacy groups and unions.